Literature DB >> 31355515

Epidermolysis bullosa pruriginosa: A rare entity which responded well to thalidomide.

Seema Rani1, Aastha Gupta1, Minakshi Bhardwaj2.   

Abstract

Epidermolysis bullosa pruriginosa is an unusual clinical variant of dystrophic epidermolysis bullosa characterized by sublamina densa blistering and intense pruritus leading to hypertrophic lichenoid nodules, plaques, milia, and variable presence of albopapuloid lesions. Most cases are sporadic but a few cases have autosomal dominant or recessive inheritance. Treatment has been quite disappointing and failed to produce satisfactory or sustained results. We report a case of 39-years-old male with epidermolysis bullosa pruriginosa and its response to thalidomide.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  epidermolysis bullosa pruriginosa; immunobullous disorder; thalidomide

Mesh:

Substances:

Year:  2019        PMID: 31355515     DOI: 10.1111/dth.13035

Source DB:  PubMed          Journal:  Dermatol Ther        ISSN: 1396-0296            Impact factor:   2.851


  2 in total

Review 1.  Small molecule drug development for rare genodermatoses - evaluation of the current status in epidermolysis bullosa.

Authors:  Verena Wally; Manuela Reisenberger; Sophie Kitzmüller; Martin Laimer
Journal:  Orphanet J Rare Dis       Date:  2020-10-19       Impact factor: 4.123

2.  Misdiagnosed dystrophic epidermolysis bullosa pruriginosa: A case report.

Authors:  Zi Wang; Yi Lin; Xing-Wu Duan; Hai-Yan Hang; Xia Zhang; Ling-Ling Li
Journal:  World J Clin Cases       Date:  2021-05-06       Impact factor: 1.337

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.